Literature DB >> 17108192

Hypoxia-induced membrane-bound apoptotic DNA particles: potential mechanism of fetal DNA in maternal plasma.

Aaron F Orozco1, Farideh Z Bischoff, Cassandra Horne, Edwina Popek, Joe Leigh Simpson, Dorothy E Lewis.   

Abstract

Fetal DNA is found in the plasma of pregnant women that appears to be stable for PCR amplification. Although the underlying mechanism giving rise to this DNA in plasma remains unclear, the source of these fragments may be from apoptotic bodies (Apo-Bodies) created from dying cells. Trophoblast apoptosis is essential for normal placental development, given the enormous amount of proliferation, differentiation, and migration during pregnancy. Through flow cytometric analysis coupled with real-time PCR, our lab has shown that aggregates of acridine orange (AO)-stained material (apoptotic particles) are resistant to DNase treatment, disrupted by sodium dodecyl sulfate (SDS), and contain fetal DNA. Because the placenta continuously re-models in an hypoxic environment, our hypothesis is that fetal DNA in maternal plasma comes from hypoxia-induced dying trophoblasts and that this DNA circulates predominantly in the form of Apo-Bodies. We have developed a model culture system for analysis of Apo-Bodies derived from JEG-3 cells, an extravillous trophoblastic cell line, undergoing various methods of cell death: hypoxia-induced, etoposide-induced, and heat stress (necrosis like)-induced cell death. Under conditions of similar propidium iodide (PI) uptake, suggesting comparable levels of death, both hypoxia- and etoposide-induced Apo-Bodies increase in concentration over time, whereas heat-induced levels of particles remain fairly constant, indicating that production of DNA-associated Apo-Bodies is a continuous process. Hypoxia, which is likely to be responsible for trophoblast cell death in vivo, produced membrane-bound Apo-Bodies containing DNA. Our results are consistent with the characteristics of membrane-bound particles containing fetal DNA found in maternal plasma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17108192     DOI: 10.1196/annals.1368.007

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  13 in total

Review 1.  Extracellular nucleic acids in maternal circulation as potential biomarkers for placental insufficiency.

Authors:  Ilona Hromadnikova
Journal:  DNA Cell Biol       Date:  2012-02-24       Impact factor: 3.311

Review 2.  Cell-free fetal nucleic acids in amniotic fluid.

Authors:  L Hui; D W Bianchi
Journal:  Hum Reprod Update       Date:  2010-10-05       Impact factor: 15.610

3.  Improving enrichment of circulating fetal DNA for genetic testing: size fractionation followed by whole gene amplification.

Authors:  Carolina J Jorgez; Farideh Z Bischoff
Journal:  Fetal Diagn Ther       Date:  2009-09-22       Impact factor: 2.587

4.  Expression profile of C19MC microRNAs in placental tissue in pregnancy-related complications.

Authors:  Ilona Hromadnikova; Katerina Kotlabova; Marketa Ondrackova; Petra Pirkova; Andrea Kestlerova; Veronika Novotna; Lucie Hympanova; Ladislav Krofta
Journal:  DNA Cell Biol       Date:  2015-03-31       Impact factor: 3.311

Review 5.  Placental apoptosis in health and disease.

Authors:  Andrew N Sharp; Alexander E P Heazell; Ian P Crocker; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2010-09       Impact factor: 3.886

6.  The amniotic fluid transcriptome: a source of novel information about human fetal development.

Authors:  Lisa Hui; Donna K Slonim; Heather C Wick; Kirby L Johnson; Diana W Bianchi
Journal:  Obstet Gynecol       Date:  2012-01       Impact factor: 7.661

7.  Placental release of distinct DNA-associated micro-particles into maternal circulation: reflective of gestation time and preeclampsia.

Authors:  A F Orozco; C J Jorgez; W D Ramos-Perez; E J Popek; X Yu; C A Kozinetz; F Z Bischoff; D E Lewis
Journal:  Placenta       Date:  2009-08-18       Impact factor: 3.481

8.  First trimester screening of circulating C19MC microRNAs can predict subsequent onset of gestational hypertension.

Authors:  Ilona Hromadnikova; Katerina Kotlabova; Lucie Hympanova; Jindrich Doucha; Ladislav Krofta
Journal:  PLoS One       Date:  2014-12-15       Impact factor: 3.240

9.  High Levels of Sample-to-Sample Variation Confound Data Analysis for Non-Invasive Prenatal Screening of Fetal Microdeletions.

Authors:  Tianjiao Chu; Suveyda Yeniterzi; Svetlana A Yatsenko; Mary Dunkel; Patricia A Shaw; Kimberly D Bunce; David G Peters
Journal:  PLoS One       Date:  2016-06-01       Impact factor: 3.240

10.  Circulating C19MC microRNAs in preeclampsia, gestational hypertension, and fetal growth restriction.

Authors:  Ilona Hromadnikova; Katerina Kotlabova; Marketa Ondrackova; Andrea Kestlerova; Veronika Novotna; Lucie Hympanova; Jindrich Doucha; Ladislav Krofta
Journal:  Mediators Inflamm       Date:  2013-11-14       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.